{"url":"https://newsforagent.com/news/2026-11-04/next-point-therapy-billing-sale","markdown_url":"https://newsforagent.com/news/2026-11-04/next-point-therapy-billing-sale.md","title":"Next Point Advises Therapy Billing Sale to Undisclosed Buyer","headline":"Next Point LLC Completes Sale of Therapy Billing Company to Undisclosed Healthcare Buyer","description":"Next Point LLC advised a privately held therapy billing and revenue cycle management company on its sale to an undisclosed buyer.","section":"Mergers & Acquisitions","published_at":"2026-11-04T05:00:55+00:00","modified_at":"2026-11-04T05:00:55+00:00","author":"News Desk","key_takeaways":["Next Point LLC served as exclusive sell-side advisor on the completed sale of a privately held therapy billing and RCM company.","The buyer is an undisclosed company in the healthcare billing sector, and financial terms remain confidential.","Managing Partner Jui Trivedi said buyers are asking tougher questions about earnings quality and client retention than a year ago.","Grant Thornton Advisors completed its acquisition of CBIZ for an enterprise value of $5 billion, according to Stock Titan."],"companies":[{"name":"Next Point LLC","is_primary":true,"profile_url":null,"website":"https://nextpointllc.com"}],"source":{"publisher":"FinancialContent Business Page","title":"Next Point LLC Advises Specialized Therapy Billing Company on Strategic Transaction Amid Shifting RCM Market","url":"https://www.financialcontent.com/article/gnwcq-2026-11-4-next-point-llc-advises-specialized-therapy-billing-company-on-strategic-transaction-amid-shifting-rcm-market"},"other_sources":[{"publisher":"Stock Titan","url":"https://www.stocktitan.net/news/CBZ/grant-thornton-advisors-completes-acquisition-of-139v7mw98vn5.html"},{"publisher":"FashionUnited","url":"https://fashionunited.com/news/business/frasers-makes-best-and-final-offer-for-accent-takeover-deal/2026110275496"},{"publisher":"EXPANSION","url":"https://www.expansion.com/empresas/banca/2026/11/02/alvarez-marsal-unico-aspirante-contrato-frob-asesorarle-caixabank.html"},{"publisher":"Yahoo","url":"https://finance.yahoo.com/markets/stocks/articles/qiagen-qgen-9-7b-takeover-081038665.html"}],"tags":["Mergers & Acquisitions","Next Point LLC"],"body_markdown":"Next Point LLC advised a privately held therapy billing and revenue cycle management company on a completed strategic sale to an undisclosed buyer in the healthcare billing sector, with financial terms kept confidential. The FinancialContent Business Page [reported](https://www.financialcontent.com/article/gnwcq-2026-11-4-next-point-llc-advises-specialized-therapy-billing-company-on-strategic-transaction-amid-shifting-rcm-market) the transaction on November 4, 2026. Next Point is an independent mergers and acquisitions advisory firm founded in 2004 that focuses on privately held businesses in healthcare and industrial sectors. The target is a privately held company that provides billing and revenue cycle management services to therapy providers.\n\n## How the Next Point Sale Was Run\n\nNext Point acted as exclusive sell-side advisor, representing the company's owners through a competitive process that drew interest from multiple qualified buyers and ended in a closing with the undisclosed buyer. The firm ran a targeted and confidential marketing effort aimed at prospective buyers with experience in healthcare services and revenue cycle management, and worked with the owners through buyer evaluation, negotiations, due diligence and closing. The identities of the parties and the financial terms remain confidential.\n\nJui Trivedi, Managing Partner of Next Point LLC, said the acquisition landscape for RCM businesses has changed. \"There's still an appetite for good RCM businesses, but buyers are asking tougher questions than they were even a year ago,\" Trivedi said. He said buyers examine the quality of earnings, the stability of the client base and what it will take to operate the business after closing.\n\nTrivedi also pointed to the transferability of client relationships as a factor in how buyers assess medical billing companies. \"Owners will tell us they've had the same clients for ten or fifteen years, and understandably, they see that as a strength,\" he said. \"But a buyer looks at those relationships differently.\" He said buyers want to know who maintains the relationships, why clients stay and what happens once the owner is no longer involved.\n\n## Grant Thornton's $5 Billion CBIZ Deal\n\nGrant Thornton Advisors completed its acquisition of CBIZ for an enterprise value of $5 billion, creating the fifth-largest U.S. Provider of professional services, tax and advisory offerings, [Stock Titan](https://www.stocktitan.net/news/CBZ/grant-thornton-advisors-completes-acquisition-of-139v7mw98vn5.html) reported on November 2, 2026. The deal, backed by New Mountain Capital, generates over $7 billion in annual revenue and includes more than 34,500 professionals across 25 or more countries. CBIZ's Benefits & Insurance Services segment will become an independent company backed by New Mountain Capital.\n\nFrasers Group declared its $0.65 per share takeover offer for Accent Group best and final, with the offer closing January 29, 2027, [FashionUnited](https://fashionunited.com/news/business/frasers-makes-best-and-final-offer-for-accent-takeover-deal/2026110275496) reported on November 2, 2026. Accent's board committee unanimously recommends rejection, citing no control premium, and the dispute follows Frasers' unsolicited bid in June 2026.\n\nQiagen agreed to a €9.7 billion cash takeover by a consortium led by EQT XI at €46.50 per share, with suspended 2026 guidance and a possible interim dividend, [Yahoo](https://finance.yahoo.com/markets/stocks/articles/qiagen-qgen-9-7b-takeover-081038665.html) reported on October 31, 2026. Analysts see a fair value of $49.20, implying the deal is overvalued, while the stock trades above the offer price.\n\n## Frasers' January 29 Deadline for Accent\n\nFrasers Group's $0.65 per share offer for Accent Group closes January 29, 2027, according to FashionUnited. Accent's board committee has unanimously recommended that shareholders reject the offer.\n","publisher":{"name":"News for Agent","url":"https://newsforagent.com"}}